Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/assessment-of-safety-and-efficacy-of-combined-trabectedin-and-low-dose-hdybmXJ01A
References (33)
-
M. Loi, M. Duijm, S. Baker, L. Rossi, D. Grunhagen, C. Verhoef, J. Nuyttens (2018)
Stereotactic body radiotherapy for oligometastatic soft tissue sarcomaLa radiologia medica, 123
-
C. Simoens, A. Korst, C. Pooter, H. Lambrechts, G. Pattyn, G. Faircloth, F. Lardon, J. Vermorken (2003)
In vitro interaction between Ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effectsBritish Journal of Cancer, 89
-
G. Rosen, C. Forscher, Susan Lowenbraun, F. Eilber, J. Eckardt, Carmack Holmes, Yao Fu (1994)
Synovial sarcoma. Uniform response of metastases to high dose ifosfamideCancer, 73
-
B. Baumann, S. Nagda, J. Kolker, W. Levin, K. Weber, A. Berman, A. Staddon, L. Hartner, S. Hahn, E. Glatstein, C. Simone (2016)
Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resectionJournal of Surgical Oncology, 114
-
National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) -
P. Navarria, A. Ascolese, L. Cozzi, S. Tomatis, G. D'Agostino, F. Rose, R. Sanctis, A. Marrari, A. Santoro, A. Fogliata, U. Cariboni, M. Alloisio, V. Quagliuolo, M. Scorsetti (2015)
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.European journal of cancer, 51 5
-
(2013)
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA, 310 20
-
M. Tavecchio, C. Natoli, P. Ubezio, E. Erba, M. D’Incalci (2007)
Dynamics of cell cycle phase perturbations by trabectedin (ET‐743) in nucleotide excision repair (NER)‐deficient and NER‐proficient cells, unravelled by a novel mathematical simulation approachCell Proliferation, 40
-
Frakulli (2015)
5581Anticancer Res, 35
-
J. Gottlieb, L. Baker, J. Quagliana, J. Luce, J. Whitecar, J. Sinkovics, S. Rivkin, R. Brownlee, E. Frei (1972)
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamideCancer, 30
-
N. Mehta, M. Selch, Pin-Chieh Wang, N. Federman, Jay Lee, F. Eilber, B. Chmielowski, N. Agazaryan, M. Steinberg, Percy Lee (2013)
Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade SarcomaSarcoma, 2013
-
G. Borst, M. Ishikawa, J. Nijkamp, M. Hauptmann, H. Shirato, R. Onimaru, M. Heuvel, J. Belderbos, J. Lebesque, J. Sonke (2009)
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 91 3
-
Lawrence Schwartz, S. Litière, E. Vries, R. Ford, S. Gwyther, S. Mandrekar, L. Shankar, J. Bogaerts, A. Chen, J. Dancey, W. Hayes, F. Hodi, Otto Hoekstra, Erich Huang, N. Lin, Yan Liu, P. Therasse, J. Wolchok, L. Seymour (2016)
RECIST 1.1-Update and clarification: From the RECIST committee.European journal of cancer, 62
-
J. Romero, I. Zapata, S. Córdoba, J. Jimeno, J. López-Martín, J. Tercero, A. Torre, J. Vargas, R. Moleron, R. Sánchez-Prieto (2008)
In vitro radiosensitisation by trabectedin in human cancer cell lines.European journal of cancer, 44 12
-
Christiane, Druml, Wolzt, Pleiner (2000)
World Medical Association Declaration of HelsinkiInternational Journal of Pharmaceutical Medicine, 14
-
C. Ryan, O. Merimsky, M. Agulnik, J. Blay, S. Schuetze, B. Tine, Robin Jones, A. Elias, E. Choy, T. Alcindor, V. Keedy, D. Reed, R. Taub, A. Italiano, X. Muro, I. Judson, J. Buck, F. Lebel, Jonathan Lewis, R. Maki, P. Schöffski (2016)
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 32
-
P. Schöffski, S. Chawla, R. Maki, A. Italiano, H. Gelderblom, E. Choy, G. Grignani, V. Camargo, S. Bauer, S. Rha, J. Blay, P. Hohenberger, D. D’Adamo, M. Guo, B. Chmielowski, A. Cesne, G. Demetri, Shreyaskumar Patel (2016)
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialThe Lancet, 387
-
W. Graaf, J. Blay, S. Chawla, Dong-Wan Kim, B. Bui-Nguyen, P. Casali, P. Schöffski, M. Aglietta, A. Staddon, Y. Beppu, A. Cesne, H. Gelderblom, I. Judson, N. Araki, M. Ouali, S. Marréaud, R. Hodge, Mohammed Dewji, C. Coens, G. Demetri, C. Fletcher, A. Tos, P. Hohenberger (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 379
-
C. Garnett, C. Palena, Mala Chakarborty, K. Tsang, J. Schlom, J. Hodge (2004)
Sublethal Irradiation of Human Tumor Cells Modulates Phenotype Resulting in Enhanced Killing by Cytotoxic T LymphocytesCancer Research, 64
-
J. Martín-Broto, A. Pousa, R. Peñas, X. Muro, A. Gutiérrez, J. Martínez-Trufero, J. Cruz, R. Álvarez, R. Cubedo, A. Redondo, J. Maurel, J. Carrasco, J. López-Martín, Á. Sala, J. Meana, R. Ramos, J. Martinez-serra, J. López-Guerrero, I. Sevilla, C. Balañà, Á. Vaz, A. Juan, R. Alemany, A. Poveda (2016)
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 19
-
A. Lindsay, Edward Haupt, C. Chan, A. Spiguel, M. Scarborough, R. Zlotecki, Parker Gibbs (2018)
Treatment of Sarcoma Lung Metastases with Stereotactic Body RadiotherapySarcoma, 2018
-
G. Demetri, M. Mehren, Robin Jones, M. Hensley, S. Schuetze, A. Staddon, M. Milhem, A. Elias, K. Ganjoo, H. Tawbi, B. Tine, A. Spira, A. Dean, N. Khokhar, Y. Park, R. Knoblauch, T. Parekh, R. Maki, Shreyaskumar Patel (2016)
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 8
-
R. Frakulli, F. Salvi, D. Balestrini, A. Parisi, M. Palombarini, S. Cammelli, M. Rocca, M. Salone, A. Longhi, S. Ferrari, A. Morganti, G. Frezza (2015)
Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.Anticancer research, 35 10
-
I. Judson, J. Verweij, H. Gelderblom, J. Hartmann, P. Schöffski, J. Blay, J. Kerst, J. Šufliarsky, J. Whelan, P. Hohenberger, A. Krarup-Hansen, T. Alcindor, T. Alcindor, S. Marréaud, S. Litière, Catherine Hermans, C. Fisher, P. Hogendoorn, A. Tos, W. Graaf (2014)
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.The Lancet. Oncology, 15 4
-
J. Martinez-serra, E. Maffiotte, Javier Martín, T. Bex, M. navarro-Palou, T. Ros, Joana Plazas, Oliver Vögler, A. Gutiérrez, J. Amat, R. Ramos, C. Saus, J. Ginés, R. Alemany, M. Diaz, J. Besalduch (2011)
Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.European journal of pharmacology, 658 2-3
-
Christina Stragliotto, K. Karlsson, I. Lax, E. Rutkowska, J. Bergh, H. Strander, H. Blomgren, S. Friesland (2012)
A retrospective study of SBRT of metastases in patients with primary sarcomaMedical Oncology (Northwood, London, England), 29
-
J. Hayes, E. David, L. Qi, A. Chen, M. Daly (2015)
Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.Clinical lung cancer, 16 5
-
W. Tap, W. Tap, Z. Pápai, B. Tine, S. Attia, K. Ganjoo, Robin Jones, S. Schuetze, D. Reed, S. Chawla, R. Riedel, A. Krarup-Hansen, M. Toulmonde, I. Ray-Coquard, P. Hohenberger, G. Grignani, L. Cranmer, S. Okuno, M. Agulnik, W. Read, C. Ryan, T. Alcindor, X. Muro, G. Budd, H. Tawbi, T. Pearce, S. Kroll, D. Reinke, P. Schöffski (2017)
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.The Lancet. Oncology, 18 8
-
H. Yamashita, W. Takahashi, A. Haga, K. Nakagawa (2014)
Radiation pneumonitis after stereotactic radiation therapy for lung cancer.World journal of radiology, 6 9
-
Sughosh Dhakal, K. Corbin, M. Milano, A. Philip, D. Sahasrabudhe, Carolyn Jones, L. Constine (2010)
Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.International journal of radiation oncology, biology, physics, 82 2
-
R. Simon (1989)
Optimal two-stage designs for phase II clinical trials.Controlled clinical trials, 10 1
-
A. Gronchi, N. Hindi, J. Cruz, J. Blay, A. López-pousa, A. Italiano, R. Alvarez, A. Gutiérrez, I. Rincon, C. Sangalli, Jose Aguiar, J. Romero, C. Morosi, M. Sunyach, R. Sanfilippo, C. Romagosa, D. Ranchère‐Vince, A. Tos, P. Casali, J. Martín-Broto (2019)
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma GroupsEClinicalMedicine, 9
-
G. Demetri, A. Cesne, S. Chawla, T. Brodowicz, R. Maki, B. Bach, D. Smethurst, S. Bray, Y. Hei, J. Blay (2012)
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study.European journal of cancer, 48 4
- Publisher
- American Medical Association
- Copyright
- Copyright 2020 American Medical Association. All Rights Reserved.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2019.6584
- Publisher site
- See Article on Publisher Site
Abstract
This nonrandomized phase 1/2 clinical trial evaluates the use of trabectedin in combination with low-dose radiotherapy for treating metastatic soft-tissue sarcomas in adult patients.
Journal
JAMA Oncology – American Medical Association
Published: Apr 20, 2020